Clinical Research Services Turku

What Clinical Research Services Turku does

Clinical Research Services Turku (CRST) is a Finnish contract research organization founded in 1995 and headquartered in Turku, Finland. According to the firmographic record, CRST offers a broad range of scientifically sound clinical, bioanalytical, and preclinical research services, positioning the company as a full-service partner for pharmaceutical and biotechnology sponsors requiring outsourced laboratory and clinical operations support. The company operates as a private, for-profit entity and its services span the early-stage research workflow — preclinical compound evaluation, bioanalytical assay work, and clinical study execution — typical of a mid-sized European CRO.

The company's revenue model is not disclosed in the available data, and no product-level breakdown, pricing model, customer list, or go-to-market details were extractable; the corporate website at crst.fi rendered only a loading/verification placeholder at the time of collection, and management team, partnership, and certification data are absent from the source. The firmographic record lists a headcount range of 5,001-10,000 employees, which appears inconsistent with the likely scale of a Turku-based CRO and is treated here as a low-confidence proxy for actual staffing. The only verifiable financial event on record is a 2014 investment from Finnvera Venture Capital, with no subsequent funding rounds, acquisitions, or strategic transactions disclosed.

On this evidence base, CRST reads as a mature, long-established specialty research services provider with no recent observable expansion, capital, or product momentum. Investors should treat this profile as data-thin: the company description above reflects only what is stated in the source, and significant gaps remain around customer base, revenue, technology stack, and competitive positioning.

Name

Clinical Research Services Turku

Website

https://crst.fi

Company type

Private

Founded year

1995

Headcount range

11–50 employees

Short description

Clinical Research Services Turku (CRST) is a Finland-based contract research organization founded in 1995 that provides clinical, bioanalytical, and preclinical research services to pharmaceutical and biotechnology clients.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB), Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD)

Keywords

• Clinical research services
• Contract research organization
• Bioanalytical research
• Preclinical research
• Clinical trial services

Headquarters

HQ city

Turku

HQ country

Finland

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Core offering

Clinical Research Services Turku (CRST) provides a broad range of scientifically sound clinical, bioanalytical, and preclinical research services to support pharmaceutical and biotechnology sponsors in drug development and testing.

Product overview

No product or service information is available in the provided source data. The source content shows only a loading/verification page from http://crst.fi/ with no substantive information about the company's offerings.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Services
• Bioanalytical Research Services
• Preclinical Research Services

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Broad incumbents

• Charles River Laboratories: Global CRO/CDMO with strong preclinical and bioanalytical offerings, headquartered in the US with European operations. Directly comparable to CRST on preclinical and bioanalytical research services, though far larger in scale.
• IQVIA: World's largest clinical CRO with extensive Nordic operations. Comparable to CRST on Phase I-IV clinical research services and bioanalytical capabilities, but operates at materially greater scale and global footprint.
• Eurofins Scientific: Global bioanalytical and life-sciences testing group headquartered in Europe with extensive operations across the continent. Comparable on the bioanalytical and laboratory-testing side of CRST's offering.
• Labcorp Drug Development (formerly Covance): Major global CRO and central laboratory network offering clinical, bioanalytical, and preclinical services. Comparable to CRST across most of its stated service portfolio, at much greater scale.

Direct peers

• ICON plc: Major global clinical CRO with significant European footprint and broad service coverage across clinical and bioanalytical phases. Closely comparable to CRST's core clinical research and bioanalytical offerings.
• Syneos Health: Biopharmaceutical services organization offering clinical development and bioanalytical solutions with strong European operations. Directly comparable on Phase I-IV clinical research to CRST.
• Medpace: Mid-sized clinical CRO focused on Phase I-IV trials across multiple therapeutic areas, with European presence. Comparable to CRST in clinical research focus and mid-market positioning, though smaller in bioanalytical scope.
• Parexel International: Global CRO with broad Phase I-IV clinical and bioanalytical service offerings. Direct competitor to CRST on clinical research and laboratory services for pharma and biotech sponsors.

Regional players

• Solventum (formerly 3M Health Care) or a Nordic regional CRO: Solvias is a Swiss-based CRO offering bioanalytical and clinical laboratory services in Europe. Comparable to CRST on bioanalytical and clinical laboratory dimensions within the European regional footprint.

Emerging players

• TFS International (now part of财PRMA): European CRO with strong Nordic and Eastern European presence, offering clinical and bioanalytical services. Comparable to CRST on regional footprint and clinical CRO service model at similar scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/crst_turku

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical Research Services Turku